Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Genetics and Molecular Research

Volume  2, Issue 2, July - December 2013, Pages 65-66
 

Letter to Editor

Vascular Endothelial Growth Factors in Diabetic Peripheral Neuropathy: Neuropathogenetic or Neuroprotective?

Kumar Senthil P., Adhikari Prabha, Jeganathan

*Founder­President, Academy of Orthopaedic Manual Physical Therapists (AOMPT)TM , Freelancer Physiotherapist and private practitioner, Mangalore, India, **Professor, Department of Medicine, ***Professor, Department of Physiology, Kasturba Medical

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI:

Abstract

Vascular endothelial growth factor (VEGF) is a growth factor gene primarily responsible for  angiogenesis, and is now hypothesized to play a role in neurodegeneration and neuroregeneration in peripheral neuropathies. The aim of this short communication was to highlight the role of VEGF in diabetic peripheral neuropathy (DPN). There is limited but sufficient evidence for role of VEGF in pathogenesis, and abnormal VEGF levels were found on assessment of DPN. Treatments with VEGF had reversed electrophysiological measures in DPN and also other treatments such as Frequency Modulated Electrical Muscle Stimulation (FREMS) was shown to increase VEGF levels, thus reiterating the diagnostic, therapeutic and prognostic role of VEGF in DPN. 

Keywords: Neurotrophic factors; VEGF; Vasa nervorum; Diabetic neuropathy. 


Corresponding Author : Kumar Senthil P.